SCHEMBL1177147

SCHEMBL1177147

CN1CCN(C)C1=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11211719 0.96
SCHEMBL8236320 0.86 INMT (0.52)
SCHEMBL8228535 0.86
SCHEMBL14344950 0.74
SCHEMBL16219094 0.73 MEN1 (0.32)
SCHEMBL1387600 0.73
SCHEMBL25337137 0.71 INMT (0.30)
SCHEMBL16218776 0.71 INMT (0.30)
SCHEMBL11101958 0.67 INMT (0.33)
SCHEMBL19063092 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025021831-A1 MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF ASTRAZENECA AB (SE) 2025-01-30 WO claimed
WO-2024181391-A1 IL-11 ANTISENSE OLIGONUCLEOTIDE 日産化学株式会社 2024-09-06 WO claimed
CN-108409605-B Preparation method of 3, 4-difluorobenzonitrile 江苏丰山集团股份有限公司 2021-02-19 CN claimed
CN-108409605-A A kind of preparation method of 3,4- difluorobenzonilyiles 江苏丰山集团股份有限公司 2018-08-17 CN claimed
EP-4656672-A1 METHOD FOR PRODUCING CURABLE COMPOSITION Kaneka Corporation (JP) 2025-12-03 EP disclosed
WO-2025111365-A1 METHOD OF PREPARING A MOISTURE CURABLE RESIN COMPOSITION WITH A NON-TIN CATALYST KANEKA AMERICAS HOLDING, INC. (US) 2025-05-30 WO disclosed
EP-4105262-B1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF KANEKA CORP (JP) 2025-04-02 EP disclosed
US-20250051771-A1 MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF ASTRAZENECA AB (SE) 2025-02-13 US disclosed
WO-2025021831-A1 MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF ASTRAZENECA AB (SE) 2025-01-30 WO disclosed
US-20240368443-A1 METHOD FOR PREPARING A POLYURETHANE POLYMER BOSTIK SA (FR) 2024-11-07 US disclosed
WO-2024181391-A1 IL-11 ANTISENSE OLIGONUCLEOTIDE 日産化学株式会社 2024-09-06 WO disclosed
WO-2024157860-A1 METHOD FOR PRODUCING CURABLE COMPOSITION 株式会社カネカ 2024-08-02 WO disclosed
EP-1992665-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2008-11-19 EP disclosed
EP-1990370-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2008-11-12 EP disclosed
US-7439395-B2 Process for the preparation of guanidinium salts MERCK PATENT GMBH (DE) 2008-10-21 US disclosed
WO-2007110363-A1 NOVEL GUANIDINE DERIVATIVES AND THEIR MEDICAL USE NEUROSEARCH A/S (DK) 2007-10-04 WO disclosed
US-20070135645-A1 Process for the preparation of guanidinium salts MERCK PATENT GMBH (DE) 2007-06-14 US disclosed
EP-0823427-B1 Process for the preparation of high purity 1,3-dialkyl-2-imidazolidinone MITSUI CHEMICALS INC (JP) 2002-10-09 EP disclosed
US-5872260-A High purity 1,3-dialkyl-2-imidazolidinone and preparation process of same MITSUI CHEMICALS, INC. (JP) 1999-02-16 US disclosed
EP-0823427-A1 High purity 1,3-dialkyl-2-imidazolidinone and preparation process of same MITSUI TOATSU CHEMICALS, Inc. (JP) 1998-02-11 EP disclosed